Revenue, 2025

USD 6.84 Billion

Forecast, 2035

USD 13.33 Billion

CAGR, 2026-2035

6.9%

Report Coverage

United States

Key Takeaways for U.S. Cath Labs Market

• U.S. cath labs market to cross USD 7.31 billion by 2026.
• Market projected at USD 13.33 billion by 2035.
• CAGR of 6.9% expected in between 2026 to 2035.
• By product type, the imaging systems segment held a dominant revenue share of 35% of the U.S. cath labs market in 2025.
• By product type, the electrophysiology equipment segment held 16% of market share in 2025 and is expected to grow at the fastest CAGR of 8.8% during the forecast period.
• By procedure type, the coronary angiography segment held a dominant revenue share of 28% of the market in 2025.
• By procedure type, the electrophysiology procedures segment held 17% of market share in 2025 and is expected to grow at the fastest CAGR of 8.7% during the forecast period.
• By application type, the coronary artery disease segment held a dominant revenue share of 42% of the market in 2025. 
• By application type, the cardiac arrhythmias segment held 18% of market share in 2025 and is expected to grow at the fastest CAGR of 8.9% during the forecast period.
• By end user, the hospitals segment held a dominant position in the U.S. cath labs market with a share of 60% in 2025.
• By end user, the ambulatory surgical centers segment held 15% of the market in 2025 and is expected to grow at the fastest CAGR of 8.4% during the forecast period.
• By technology type, the digital cath labs segment held a dominant revenue share of 38% of the market in 2025.
• By technology type, the AI-enabled cath labs segment held 8% of market share in 2025 and is expected to grow at the fastest CAGR of 11.2% during the forecast period.

U.S. Cath Labs Market Trends for 2026

The U.S. cath labs market size was estimated at USD 6.84 billion in 2025 and is predicted to increase from USD 7.31 billion in 2026 to approximately USD 13.33 billion by 2035, expanding at a CAGR of 6.9% from 2026 to 2035. The increasing cardiovascular disease burden in the U.S. is increasing the dependence on the cath labs. Growing outpatient services, health awareness, AI innovations, and new product launches are also enhancing the market growth.

What are the U.S. Cath Labs?

The U.S. cath labs market is driven by a growing geriatric population and a shift towards minimally invasive procedures. The U.S. cath labs, also known as catheterization laboratories, refer to the hospital or clinical rooms offering diagnosis and treatment of heart conditions with the use of flexible and thin catheters across the U.S. They offer coronary angiography, angioplasty, stent placement, promoting the treatment of heart valve disorders, heart attacks, etc., as well as provide implantation of various cardiac devices.

What are the Applications of AI in the U.S. Cath Labs Market?

AI offers a wide range of applications in the U.S. cath labs, driving real-time image analysis and enhancing decision-making. It also helps in assessing disease progression, enhanced procedural planning, and optimized implant placements. AI also helps in offering 3D imaging, predicting patient outcomes, navigating complex catheter-based procedures, and reducing operator variability.

What are the Major Trends & Future Outlook of the U.S. Cath Labs Market?

Minimally Invasive Procedures on the Rise

Increasing health awareness across the U.S. is driving the demand for minimally invasive approaches. This, in turn, is increasing the use of cath labs offering minimally invasive diagnostics, catheter-based treatment with shorter recovery times, and lower complications.

Expanding Structural Heart Interventions

The growing cardiovascular disease burden in the U.S. is promoting advancements in structural heart interventions. This is in turn, is promoting the use of transcatheter aortic valve replacement, left atrial appendage closure, transcatheter mitral valve repair and replacement, and patent foramen ovale closure procedures.

Blooming Imaging Technologies

The growing investments in the cath labs are promoting the development of advanced imaging technologies. This is driving the development of 3D imaging systems, fusion imaging, intravascular ultrasound, and optical coherence tomography systems.

Key Indicators and Highlights

Segmental Insights

By Product Type Insights

The Imaging Systems Segment Dominated the Market With 35% in 2025

The imaging systems segment led the U.S. cath labs market with a 35% share in 2025, due to growth in hospitals replacing aging fluoroscopy platforms. The rise in hybrid imaging demand has also increased its use. Advanced visualization also improved procedural outcomes.

The electrophysiology equipment segment held the second-largest share of 16% of the market in 2025 and is expected to witness the fastest growth with a CAGR of 8.8% during the forecast period, due to the rising prevalence of arrhythmia, which expands EP procedures. Advanced mapping technologies also improve their precision. Growing ablation volumes also increase their use.

The consumables & disposables segment held 16% of the U.S. cath labs market share in 2025, driven by high procedure volumes, which drive recurring demand. Single-use devices also improve safety. Growth in interventional procedures also boosts their consumption.

The hemodynamic monitoring systems segment held 15% of the market share in 2025 due to real-time physiological assessment, which supports complex interventions. Digital integration also helps in enhancing workflow. Growing procedure volumes also sustain their adoption.

By Procedure Type Insights

The Coronary Angiography Segment Dominated the Market With 28% in 2025

The coronary angiography segment accounted for the highest revenue share of 28% of the U.S. cath labs market in 2025, as it remained the primary diagnostic cardiac procedure. An aging population also expanded the patient pool, driving demand. A rise in early disease detection also supported their increased use.

The percutaneous coronary intervention (PCI) segment held the second-largest share of 25% of the market in 2025, due to the increasing coronary artery disease burden, which drives its demand. Improved stent technologies also enhance their outcomes. Rapid treatment protocols also support their utilization.

The electrophysiology procedures segment held 17% of the U.S. cath labs market share in 2025 and is expected to show the highest growth with a CAGR of 8.7% during the forecast period, driven by the rising atrial fibrillation incidence, which expands EP volumes. Mapping innovations helps in improving their success rates. Growing physician expertise also supports their adoption.

The structural heart procedures segment held 14% of the market share in 2025, due to TAVR and valve repair procedures continuing to expand. Elderly patients seek minimally invasive treatment, promoting their use. Clinical evidence also strengthens their adoption.

By Application Insights

The Coronary Artery Disease Segment Dominated the Market With 42% in 2025

The coronary artery disease segment held a major revenue share of 42% of the U.S. cath labs market in 2025, as CAD remained the leading cardiovascular indication. Lifestyle risk factors also increased disease burden, promoting the use of cath labs. Growth in the intervention rates also increased their use.

The cardiac arrhythmias segment held the second-largest share of 18% of the market in 2025 and is expected to expand rapidly with a CAGR of 8.9% during the forecast period, driven by the rising AFib prevalence, which increases treatment demand. EP technologies also help in improving procedural success. Earlier diagnosis also expands patient volumes.

The structural heart disease segment held 14% of the U.S. cath labs market share in 2025, due to the growing elderly population, which requires valve interventions. Minimally invasive procedures are also enhancing their acceptance rates. Their improving clinical outcomes also drive their demand.

The peripheral artery disease segment held 12% of the market share in 2025, driven by growing diabetes prevalence, which increases vascular complications. Endovascular treatment adoption also promotes their expansion. Increasing screening initiatives also increases their diagnostic rates.

By End User Insights

The Hospitals Segment Dominated the Market With 60% in 2025

The hospitals segment contributed the biggest revenue share of 60% of the U.S. cath labs market in 2025, due to major cardiovascular procedures remaining hospital-centered. Large budgets also supported technology upgrades. High patient throughput also sustained their demand.

The ambulatory surgical centers segment held the second-largest share of 15% of the market in 2025 and is expected to gain the highest share with a CAGR of 8.4% during the forecast period, as outpatient interventions continue expanding. Expanding cost-efficient care models are also increasing their acceptance rate. Reimbursement support also accelerates their growth.

The cardiology clinics segment held 10% of the U.S. cath labs market share in 2025, driven by increased diagnostic procedures. Their enhanced patient convenience also increases their utilization. Integrated care pathways also drive their growth.

The specialty heart institutes segment held 10% of the market share in 2025, due to advanced cardiac programs attracting referrals. Focusing on innovation also supports investments. Growing procedural complexity also increases their demand.

By Technology Insights

The Digital Cath Labs Segment Dominated the Market With 38% in 2025

The digital cath labs segment held the largest revenue share of 38% of the U.S. cath labs market in 2025, driven by digital imaging, which improved workflow and visualization. Hospitals prioritized modernization, which encouraged their use. Better data integration also promoted their adoption.

The conventional cath labs segment held the second-largest share of 22% of the market in 2025, due to the existing installed base remaining substantial. Budget-conscious facilities also continue their utilization. Replacement cycles also remain gradual.

The hybrid cath labs segment held 20% of the U.S. cath labs market share in 2025, driven by complex structural procedures requiring hybrid environments. Multidisciplinary care also expands its demand. Increasing hospitals' investments in advanced infrastructure is also promoting their growth.

The AI-enabled cath labs segment held 8% of the market share in 2025 and is expected to grow with the fastest CAGR of 11.2% during the forecast period, as AI enhances image analysis and workflow optimization. Predictive insights also improve efficiency. Hospitals are also accelerating digital transformation.

Regional Insights

Growing Cardiovascular Disease Burden Propels U.S.

The U.S. cath labs market is expected to show considerable growth during the forecast period, due to the growth in cardiovascular diseases. A rise in the geriatric population and health awareness has also increased their dependence on the cath labs. Advancements in medical devices and structural heart procedures also contributed to the market growth.

U.S. Cath Labs Market Value Chain Analysis

R&D

• The R&D of the U.S. cath labs focuses on the development of next-generation PFA ablation systems, robotic-assisted intervention, transcatheter structural heart devices, and AI integration.
• Key players: Abbott Laboratories, Medtronic plc, Boston Scientific Corporation.

Clinical Trials and Regulatory Approvals

• The clinical safety, procedural efficacy, radiation dose reduction, and long-term durability are evaluated in the clinical trials and regulatory approvals of the U.S. cath labs.
• Key players: Abbott Laboratories, Medtronic plc, Boston Scientific Corporation.

Patient Support and Services

• Multilingual patient education applications, post-discharge digital monitoring platforms, and dedicated financial reimbursement navigation lines are provided in the patient support and services of the U.S. cath labs.
• Key players: Abbott Laboratories, Medtronic plc, Boston Scientific Corporation.

Who are the U.S. Cath Labs Market Top Vendors and What are Their Offerings?

SWOT Analysis

Strengths

• The cath labs offer minimally invasive diagnostic and treatment options, which increases their preference across the U.S.
• Their real-time imaging and faster treatment also attract the patients.
• Their high accuracy and advanced technologies also increase their use.
• Procedures like stent placement, electrophysiology interventions, and angioplasty also help in reducing the chances of open-heart surgeries.

Weaknesses

• Shortage of skilled personnel acts as the major weakness in the U.S. cath labs market, limiting their expansion.
• The requirement for system maintenance and upgrades also reduces their use.

Opportunities

• Growing cardiovascular disease prevalence across the U.S. is increasing the demand for cath labs.
• Increasing shift towards minimally invasive procedures is also promoting their use.
• Growing innovation and health awareness are also driving their use.
• Expanding technological advancements are also promoting their innovations.

Threats

• High cost associated with raw materials, semiconductors, and electronics reduces the cath labs' system innovations.
• Stringent regulations and risk of product recall also limit their advancements.

Recent Developments in the U.S. Cath Labs Market

• In April 2026, after the 510(k) U.S. Food and Drug Administration (FDA) clearance, the Synchrony system was launched by Stereotaxis for cath laboratories. The system offers a 55-inch 4K ultra-high-definition display, an intuitive user interface, customisable layouts, and improved workflow, promoting advanced digital capabilities in interventional cath labs.
• In October 2025, YorLabs Intracardiac Imaging System, which is a first-of-its-kind, zero-capex ultrasound platform, was announced to have received U.S. FDA 510(k) clearance by YorLabs, Inc. The platform helps in enhancing procedural efficiency, simplifying workflow, and reducing cost inside the cath lab.

Segments Covered in the Report

By Product Type

• Imaging Systems
  • Fixed C-Arm Systems
  • Biplane Imaging Systems
  • Hybrid Cath Lab Imaging Systems
• Hemodynamic Monitoring Systems
  • Recording Systems
  • Physiological Monitoring Systems
• Contrast Injection Systems
  • Automatic Injectors
  • Syringeless Injectors
• Electrophysiology Equipment
  • Mapping Systems
  • Ablation Systems
• Cath Lab Furniture & Accessories
  • Procedure Tables
  • Ceiling-Mounted Equipment
  • Radiation Shields
• Consumables & Disposables
  • Catheters
  • Guidewires
  • Balloons
  • Introducer Sheaths
  • Closure Devices

By Procedure Type

• Coronary Angiography
• Percutaneous Coronary Intervention (PCI)
• Electrophysiology Procedures
  • Diagnostic EP Studies
  • Cardiac Ablation
• Structural Heart Procedures
  • TAVR
  • Mitral Valve Repair
  • Left Atrial Appendage Closure
• Peripheral Vascular Procedures
  • Peripheral Angioplasty
  • Peripheral Stenting
• Neurovascular Procedures
  • Stroke Intervention
  • Aneurysm Treatment

By Application

• Coronary Artery Disease
• Cardiac Arrhythmias
• Structural Heart Disease
• Peripheral Artery Disease
• Congenital Heart Disease
• Neurovascular Disorders

By End User

• Hospitals
• Ambulatory Surgical Centers
• Cardiology Clinics
• Specialty Heart Institutes
• Research & Teaching Institutions

By Technology

• Conventional Cath Labs
• Digital Cath Labs
• Hybrid Cath Labs
• AI-Enabled Cath Labs
• Robotic-Assisted Cath Labs

By Facility Type

• Hospital-Based Cath Labs
  • Academic Medical Centers
  • Community Hospitals
• Ambulatory Surgical Centers (ASCs)
• Office-Based Labs (OBLs)
• Specialty Cardiac Centers

By Ownership Model

• Public Hospitals
• Private Hospitals
• Physician-Owned Labs
• Integrated Health Systems